title: Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia.
authors.forename: Nobukiyo
authors.initials: N
authors.lastname: Tanaka
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Momiyama
authors.forename: Reiko
authors.initials: R
authors.lastname: Ohmori
authors.forename: Atsushi
authors.initials: A
authors.lastname: Yonemura
authors.forename: Makoto
authors.initials: M
authors.lastname: Ayaori
authors.forename: Masatsune
authors.initials: M
authors.lastname: Ogura
authors.forename: Shojiro
authors.initials: S
authors.lastname: Sawada
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Kusuhara
authors.forename: Haruo
authors.initials: H
authors.lastname: Nakamura
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Ohsuzu
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000188:drug therapy*; D053495:Osteopontin; D011758:Pyrroles / Q000627:therapeutic use*; D012795:Sialoglycoproteins / Q000097:blood*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin; D000069059:Atorvastatin